By spending just Rs 6,000 crore, the government can make a huge dent in the treatment of all sick people across the whole country — currently, people are spending as much as Rs 25,000 crore on buying essential medicines. This was the strong message sent out from a National Consultation organized by several civil society groups at New Delhi on Tuesday. Officials of the health ministry and the Planning Commission...

Is the Indian government bargaining away the rights of millions across the world to essential drugs supplied by India, hailed as the pharmacy of the developing world, in the name of free trade with the European Union (EU)? That's a fear being expressed by civil society groups in the developing world. Commerce minister Anand Sharma vehemently denies such a possibility, claiming that the free trade agreement (FTA) under negotiation with...

Is India’s brand new Seed Bill capable of protecting the farmers' livelihoods? Or will it compromise their interest by allowing multinational seed companies to have a free run of the Indian seed market? The new Bill seeks to regulate the seed market and improve the quality of seeds as well as to harmonise and update the old policies in line with the current international practices for production, supply and for...

The poor health indices and health care in rural India have always been met with lofty ideals sans action; they demand urgent and radical solutions.  The recent proposal to introduce a new medical course, Bachelor of Rural Health Care, has been met with resistance from many sections of the medical fraternity. Its opponents argue that it will result in second-class health care for rural India and increase the rural-urban divide....

India has played a crucial role in making essential medicines available and affordable for patients in the developing world through generic drugs. This has been possible by linking India’s patent policies and laws to public interest. Similarly, policies that align public funded R&D in India with public health have the potential to provide incentives to the development of medical technologies (vaccines, diagnostics and medicines) crucial for treating neglected diseases like...